Results

Total Results: 326 records

Showing results for "prescribed".

101. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Cjgb95YGBUaHjfn3MNR9xz
     September 28, 2021 - Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force Summary of Recommend…

102. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ymZSPeLcwZ9rxTC-7zdWbp
     July 11, 2022 - JAMA Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force Summary of Recommendation See the Summary of Recommendation figure. Importance Preeclampsia is one of the most serious health problems that affe…

103. Screening for Iron Deficiency Anemia and Iron Supplementation in Pregnant Women to Improve Maternal Health and Birth Outcomes (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/2VxcSta8ko2L_GC97XjZqm
     September 01, 2015 - Screening for Iron Deficiency Anemia and Iron Supplementation in Pregnant Women to Improve Maternal Health and Birth Outcomes September 2015 Task Force FINAL Recommendation | 1 Understanding Task Force Recommendations Screening for Iron Deficiency Anemia and Iron Supplementation in Pregnant Women to Improve Mate…

104. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/SToafQ-B-qpCqz5_Jf43wK
     March 21, 2022 - Statin Use for the Primary Prevention of Cardiovascular Disease in Adults Comment Period from February 22, 2022, to March 21, 2022 1 Understanding Task Force Draft Recommendations This fact sheet explains the U.S. Preventive…

105. Archived: Chronic Obstructive Pulmonary Disease (COPD): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/chronic-obstructive-pulmonary-disease-copd-screening-2008
     March 15, 2008 - anxiety associated with false-positive results, and adverse effects from appropriately or inappropriately prescribed

106. Draft Recommendation: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
     April 19, 2022 - and fracture. 33 The North American Menopause Society recommends that hormone therapy should not be prescribed

107. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - Dosage A reasonable approach consistent with the evidence is to prescribe 81 mg/d (the most commonly prescribed … pragmatic approach consistent with the evidence is to prescribe 81 mg per day, which is the most commonly prescribed

108. U.S. Preventive Services Task Force Final Recommendation Statement on Medications for Risk Reduction of Primary Breast Cancer in Women (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/LVNk5s8choFWvCWQuNsqTk
     September 01, 2013 - U.S. Preventive Services Task Force Final Recommendation Statement on Medications for Risk Reduction of Primary Breast Cancer in Women September 2013 Task Force FINAL Recommendation | 1 Understanding Task Force Recommendations Medications for the Risk Reduction of Primary Breast Cancer in Women The U.S. Preven…

109. Final Evidence Summary: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/drug-use-illicit-screening
     June 09, 2020 - harms (KQ5) of interventions to reduce drug use, and the benefits (KQ6) and harms (KQ7) of preemptively prescribed … For KQ6 and KQ7, studies of preemptive naloxone prescribed in clinical settings as a rescue medication

110. Screening and Interventions to Prevent Dental Caries in Children Younger Than Age 5 Years (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Cq-tgmsk-bEBSDs_HGWKhE
     June 07, 2021 - Screening and Interventions to Prevent Dental Caries in Children Younger Than Age 5 Years Comment Period from May 11, 2021 to June 7, 2021 Task Force DRAFT Recommendation | 1 Understanding Task Force Draft Recommendations This fact sheet explains the U.S. Preventive Services Task Force’s (Task Force)…

111. U.S. Preventive Services Task Force Final Recommendation Statement on Medications for Risk Reduction of Primary Breast Cancer in Women (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breastcanmedsfact.pdf
     September 01, 2013 - U.S. Preventive Services Task Force Final Recommendation Statement on Medications for Risk Reduction of Primary Breast Cancer in Women September 2013 Task Force FINAL Recommendation | 1 Understanding Task Force Recommendations Medications for the Risk Reduction of Primary Breast Cancer in Women The U.S. Preven…

112. Archived: Suicide Risk: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/suicide-risk-screening-1996
     January 01, 1996 - Studies of deaths by drug overdose have found that, in over half of cases, the ingested drugs were either prescribed

113. Archived: Postmenopausal Hormone Prophylaxis: Preventive Medication, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/postmenopausal-hormone-prophylaxis-preventive-medication-1996
     January 01, 1996 - These results suggest that MPA, the most commonly prescribed pro-gestin in the U.S., 44 may attenuate … long term follow-up of a smaller British cohort, 81 or in 12-year follow-up of 23,000 Swedish women prescribed

114. Archived: Folic Acid to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-to-prevent-neural-tube-defects-preventive-medication
     May 15, 2009 - archived Final Recommendation Statement Folic Acid to Prevent Neural Tube Defects: Preventive Medication May 15, 2009 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality …

115. Archived: Folic Acid to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-to-prevent-neural-tube-defects-preventive-medication-2009
     May 15, 2009 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Folic Acid to Prevent Neural Tube Defects: Preventive Medication May 15, 2009 Recommendations made by the USPSTF are independe…

116. Draft Recommendation: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/screening-anxiety-children-adolescents
     April 12, 2022 - Other medications have also been reported as being prescribed off-label for treatment of anxiety in youth

117. Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Breast Cancer: Medication Use to Reduce Risk September 03, 2019 Recommendations made by the USPSTF are independent of the U.S. government. They sho…

118. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/by8VJVre6h6BmadrGxaFMM
     April 01, 2016 - Dosage A reasonable approach consistent with the evidence is to prescribe 81 mg/d (the most commonly prescribed … pragmatic approach consistent with the evidence is to prescribe 81 mg per day, which is the most commonly prescribed

119. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Breast Cancer: Medication Use to Reduce Risk September 03, 2019 Recommendations made by the USPSTF are independent of the U.S. government. They should not be con…

120. Archived: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/impaired-visual-acuity-in-older-adults-screening1
     July 15, 2009 - Approximately one half of the participants were prescribed new eyeglasses or were referred for further